Long-term electrical performance of Attain Performa quadripolar left ventricular leads with all steroid-eluting electrodes: Results from a large worldwide clinical trial.
Albert C LinMauro BiffiDerek V ExnerW Ben JohnsonDaniel GrasAzlan HussinBalbir SinghZhongping YangDouglas HineShelby LiGeorge H CrossleyPublished in: Pacing and clinical electrophysiology : PACE (2018)
This clinical trial demonstrated that SE on all LV pacing electrodes is associated with low and stable PCTs for all quadripolar LV lead electrodes, resulting in multiple viable vectors for LV pacing. The large number of available vectors facilitates basal pacing, avoidance of PNS, and potentially prolongs generator longevity due to lower PCTs.
Keyphrases
- cardiac resynchronization therapy
- left ventricular
- clinical trial
- heart failure
- reduced graphene oxide
- carbon nanotubes
- solid state
- phase ii
- hypertrophic cardiomyopathy
- open label
- acute myocardial infarction
- study protocol
- left atrial
- double blind
- mitral valve
- aortic stenosis
- phase iii
- gene therapy
- randomized controlled trial
- gold nanoparticles
- coronary artery disease
- atrial fibrillation
- placebo controlled